Furthermore, we found that even in one-year follow up, GLP-1 can reduce the risk of osteoporosis and the HR is lower with the longer duration of follow up, which means GLP-1 RAs might have a lasting influence on bone metabolism. The gene discussed is GLP1R; the disease is osteoporosis.